Innovations in Diabetic Wound Care, What’s Next in Foot Ulcer Treatment
The global diabetic foot ulcer (DFU) therapeutics market is expected to grow from US$ 7,578.5 million in 2025 to US$ 11,246.8 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.8% over the forecast period from 2025 to 2032. Diabetic foot ulcers have emerged as a significant public health issue, contributing to reduced quality of life, increased healthcare costs, and prolonged hospital stays for individuals with diabetes.